Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering Prodrug Nanomedicine for Cancer Immunotherapy
Bin Yang, Jing Gao, Qing Pei, et al.
Advanced Science (2020) Vol. 7, Iss. 23
Open Access | Times Cited: 96

Showing 26-50 of 96 citing articles:

Stimuli-activatable PROTACs for precise protein degradation and cancer therapy
Jing Gao, Lei Yang, Shumin Lei, et al.
Science Bulletin (2023) Vol. 68, Iss. 10, pp. 1069-1085
Closed Access | Times Cited: 34
Cancer cell membrane–encapsulated biomimetic nanoparticles for tumor immuno-photothermal therapy
Wen Li, Tiantian Ma, He Tian, et al.
Chemical Engineering Journal (2023) Vol. 463, pp. 142495-142495
Closed Access | Times Cited: 33
Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review
Renshuai Zhang, Xiaohua Zhao, Ang Jia, et al.
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125993-125993
Closed Access | Times Cited: 30
Biomaterials Elicit Pyroptosis Enhancing Cancer Immunotherapy
Meng‐Jie Zhang, Yuanyuan Wang, Lin‐Lin Han, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 7
Closed Access | Times Cited: 25
Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches
Natalie Fuchs, Longfei Zhang, Laura Calvo‐Barreiro, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 68-68
Open Access | Times Cited: 10
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 9
Ultrasound-Activated PROTAC Prodrugs Overcome Immunosuppression to Actuate Efficient Deep-Tissue Sono-Immunotherapy in Orthotopic Pancreatic Tumor Mouse Models
Ye Liu, Haiyang Wang, Mengchao Ding, et al.
Nano Letters (2024) Vol. 24, Iss. 28, pp. 8741-8751
Closed Access | Times Cited: 9
Inspired Epigenetic Modulation Synergy with Adenosine Inhibition Elicits Pyroptosis and Potentiates Cancer Immunotherapy
Hong‐Gang Xiong, Xianbin Ma, Xiaolong Wang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 20
Closed Access | Times Cited: 55
Engineering Chameleon Prodrug Nanovesicles to Increase Antigen Presentation and Inhibit PD‐L1 Expression for Circumventing Immune Resistance of Cancer
Fengqi Zhou, Jing Gao, Yang Tang, et al.
Advanced Materials (2021) Vol. 33, Iss. 43
Open Access | Times Cited: 51
Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1493-1493
Open Access | Times Cited: 38
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
Meihua Yu, Wei Yang, Wenwen Yue, et al.
Advanced Science (2022) Vol. 9, Iss. 35
Open Access | Times Cited: 38
Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
Yi Lu, Yue Gao, Huan Yang, et al.
Military Medical Research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 36
The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy
Lingling Huang, Xiaoyan Ge, Yang Liu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 6, pp. 1228-1228
Open Access | Times Cited: 34
Supramolecular nanomedicines through rational design of self-assembling prodrugs
Han Wang, Maya K. Monroe, Faith Leslie, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 6, pp. 510-521
Open Access | Times Cited: 32
Immunoprotection of cellular transplants for autoimmune type 1 diabetes through local drug delivery
Taylor R. Lansberry, Cherie L. Stabler
Advanced Drug Delivery Reviews (2024) Vol. 206, pp. 115179-115179
Open Access | Times Cited: 6
Tumor Microenvironment Activatable Nanoprodrug System for In Situ Fluorescence Imaging and Therapy of Liver Cancer
Can Xie, Yongbo Peng, Zhen Zhang, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 12, pp. 5006-5013
Closed Access | Times Cited: 6
A Synergistic Chemoimmunotherapy System Leveraging PD‐L1 Blocking and Bioorthogonal Prodrug Activation
Kewei Wang, Maolin Jiang, Tao Li, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 6
Semiconducting polymer nanoprodrugs enable tumor-specific therapy via sono-activatable ferroptosis
Fengshuo Wang, Zhiting Wu, Yijing Zhang, et al.
Biomaterials (2024) Vol. 312, pp. 122722-122722
Closed Access | Times Cited: 6
Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy
Jiayi Ye, Bo Hou, Fangmin Chen, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 6, pp. 2695-2709
Open Access | Times Cited: 41
Biomaterials‐Based Delivery of Therapeutic Antibodies for Cancer Therapy
Qian‐Ni Ye, Yue Wang, Song Shen, et al.
Advanced Healthcare Materials (2021) Vol. 10, Iss. 11
Closed Access | Times Cited: 38
Nanotechnology, Nanomedicine, and the Kidney
Péter Hauser, Hsiao-Min Chang, Norimoto Yanagawa, et al.
Applied Sciences (2021) Vol. 11, Iss. 16, pp. 7187-7187
Open Access | Times Cited: 37
Tumor-overexpressed enzyme responsive amphiphiles small molecular self-assembly nano-prodrug for the chemo-phototherapy against non-small-cell lung cancer
Peilian Liu, Yong Huang, Chenyue Zhan, et al.
Materials Today Bio (2023) Vol. 21, pp. 100722-100722
Open Access | Times Cited: 15
Recent Advances in Engineering Prodrug-based Nanomedicines for Cancer Therapy
Linlin Shi, Shanshan Lin, Fengping Zhou, et al.
Materials Advances (2024) Vol. 5, Iss. 11, pp. 4634-4659
Open Access | Times Cited: 5
Engineering Bioinspired Nanomedicines to Mitigate the Resistance to Cancer Immunotherapy
Jiayi Ye, Bo Hou, Madiha Saeed, et al.
Accounts of Materials Research (2022) Vol. 3, Iss. 7, pp. 697-708
Closed Access | Times Cited: 21
Systemic Delivery of mPEG‐Masked Trispecific T‐Cell Nanoengagers in Synergy with STING Agonists Overcomes Immunotherapy Resistance in TNBC and Generates a Vaccination Effect
Ming Shen, Chuanrong Chen, Qianqian Guo, et al.
Advanced Science (2022) Vol. 9, Iss. 32
Open Access | Times Cited: 21

Scroll to top